Tag Archives: Clinical Dementia Rating (CDR)

One Hour of Social Interaction Per Week Improves Dementia Care (NIHR / NHS Choices / PLoS Medicine)

Posted on February 23, 2018 by Dementia and Elderly Care News

Summary NIHR-funded research indicates that a modest amount of social interaction improves quality of life for people with dementia living in care homes. Agitation and aggression were reduced by these cost-effective means, and the quality of life in people with … Continue reading →

Posted in Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Management of Condition, Mental Health, Models of Dementia Care, NHS Digital (Previously NHS Choices), NIHR, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Personalisation, Quick Insights, UK, Universal Interest | Tagged Abbey Pain Scale, Advancing Care: Research With Care Homes (NIHR), Agitation, Agitation and Aggression, Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotics, Alzheimer's Society, Antipsychotic Prescribing in Care Homes, Antipsychotic Prescribing in Nursing Homes, Antipsychotics Limitation in Dementia, Bangor University, Bazian, Behavioural Alternatives to Antipsychotic Drugs, Behind the Headlines, Camberwell Assessment of Need for the Elderly, Care Homes, Centre for Age-Related Medicine (SESAM): Helse Stavanger University Hospital, Clinical Dementia Rating (CDR), Clinical Dementia Rating Scale, CMAI (Cohen Mansfield Agitation Inventory), Cohen-Mansfield Agitation Inventory (CMAI), Cohen-Mansfield Agitation Inventory (CMAI) Scores, Cornell Scale for Depression in Dementia (CSDD), Dementia Services Development Centre Wales: Bangor University, Dementia-Related Agitation, DEMQOL-Proxy, DEMQoL-Proxy: Dementia Quality of Life Proxy, Division of Psychiatry and Applied Psychology: University of Nottingham, Division of Psychiatry: University College London, Encouraging Independence and Social Interaction, Exeter University, Exeter University Medical School: Exeter University, Faculty of Health and Social Sciences: University of Hull, Helse Stavanger University Hospital (Norway), Improving Wellbeing and Health for People with Dementia (WHELD) Trial, Institute of Mental Health: University of Nottingham, Kings College London, London School of Economics, Managing Agitation, National Institute for Health Research (NIHR), National Institute for Health Research Signal, Neuroleptic Discontinuation, Neuropsychiatric Inventory-Nursing Home version (NPI-NH), NIHR Programme Grants for Applied Research (PGfAR) Programme, NIHR Signal, Norway, Nursing Homes, Oxford Health NHS Foundation Trust, People With Dementia Living in Care Homes, People With Dementia Living in Nursing Homes, Person-Centred Activities for People With Dementia Living in Nursing Homes, Person-Centred Care Training for People With Dementia Living in Nursing Homes, Personalised Social Interaction, PLoS Medicine, Professor Martin Orrell, Programme Grants for Applied Research (PGfAR) Programme (NIHR), Quality of Interactions Scale (QUIS), Reducing Agitation and Distress, Reducing Antipsychotic Drugs in Care Homes, Reducing Antipsychotic Medication in Care Homes, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics, Reducing Violence and Aggression, Residential Care, Residential Care Homes, Social Interaction, University College London, University of Hull, University of Nottingham, WHELD Intervention, WHELD Programme, Wolfson Centre for Age-Related Diseases: King’s College London | Leave a comment

Development of Standardised Intervention Outcome Measures for Dementia Prevention (PLoS One / HTA)

Posted on July 25, 2017 by Dementia and Elderly Care News

Summary The following articles present work towards establishing a consensus on the most suitable outcomes to be measured when assessing “disease modification” (or the lack of it) in response to interventions intended to delay or prevent the progress of dementia. … Continue reading →

Posted in Alzheimer's Society, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Mental Health, Models of Dementia Care, Quick Insights, Standards, Systematic Reviews, UK | Tagged Activities of Daily Living (ADLs), Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog), Alzheimer's Society, Alzheimer’s Disease Clinical Trials, and Health Psychology: University College London, Assessment of Quality of Life, Aston Research Centre for Healthy Ageing: Aston University, Aston University, Bangor University, Biological Markers, Biomarkers, Brighton and Sussex Medical School, Cambridge Institute of Public Health: University of Cambridge, Camden and Islington NHS Foundation Trust, Cardiff University, Centre for Dementia Studies: Brighton and Sussex Medical School, Centre for Public Health: Queen's University Belfast, Centre for Research in Primary and Community Care: University of Hertfordshire, Clinical Dementia Rating (CDR), Clinical Dementia Rating Scale, Core Outcome Measures in Effectiveness Trials, Dementia Quality of Life (DEMQOL), Dementia Quality of Life Measure, Dementia Services Development Centre Wales: Bangor University, Department of Psychiatry and Psychotherapy: Ludwig-Maximilians-Universität München, Department of Psychiatry and Psychotherapy: Technische Universität München, Department of Psychiatry: University of Cambridge, Disability Assessment for Dementia-DAD, Disease Modification, Disease Modification Trials, Disease-Modifying Trials in Mild-to-Moderate Dementia, Division of Psychiatry: University College London, Division of Psychology and Language Sciences: University College London, Drug Trials Failure Rate, Faculty of Health and Social Care: University of Hull, Faculty of Medicine: Imperial College London, Germany, Health Technology Assessment (HTA) Programme, Health Technology Assessment Study, Health Technology Assessments, Imperial College London, Institute of Brain Behaviour and Mental Health: University of Manchester, Institute of Health and Society: Newcastle University, Institute of Mental Health: University of Nottingham, International Consortium for Health Outcomes Measurement, Kings College London, Leeds Beckett University, Ludwig-Maximilians-Universität München, Magnetic Resonance Imaging (MRI), Measurement of Successes and Failures of Dementia Treatments, Measuring the Impact of Interventions to Reduce Alzheimer’s Disease, Mini Mental State Examination (MMSE), National Institute for Health Research (NIHR), National Institute for Health Research: Health Technology Assessment Programme, Neuropsychiatric Inventory (NPI), Neuropsychiatric Inventory (NPI) Agitation / Aggression Scale, Neuropsychiatric Inventory Agitation / Aggression Domain (NPI), Neuropsychiatric Symptoms, Neuropsychiatric Symptoms in People With Dementia, Neuroscience Research Centre - St. George's: University of London, Newcastle University, NIHR Health Technology Assessment (HTA) Programme, NIHR HTA: Health Technology Assessment Programme, North Thames CLAHRC, Norwich Medical School: University of East Anglia, Nuffield Department of Population Health: University of Oxford, Opportunities for Standardisation, Outcome Measures for Disease-Modifying Trials in Mild-to-Moderate Dementia, Outcome Validation, Oxford Health NHS Foundation Trust, Patient and Public Involvement (PPI), PenCLAHRC: University of Exeter Medical School, Personal Social Services Research Unit: University of Manchester, Potential Treatment for Alzheimer’s Disease, Queen's University Belfast, Research Department of Clinical Educational, Research Institute for the Care of Older People (RICE): University of Bath, ScHARR: University of Sheffield, School of Clinical Sciences: University of Bristol, School of Health and Community Studies: Leeds Beckett University, School of Healthcare Sciences: Cardiff University, School of Medicine: University of Southampton, School of Psychology: University of Exeter, School of Public Health: Imperial College London, sMRI (Structural Magnetic Resonance Imaging), Standardisation, Systematic Reviews and Meta-Analyses, Technische Universität München, United Kingdom, University College London, University of Bath, University of Bristol, University of Cambridge, University of East Anglia, University of Exeter, University of Exeter Medical School, University of Hertfordshire, University of Hull, University of London, University of Manchester, University of Nottingham, University of Oxford, University of Sheffield, University of Southampton, University of Warwick, Warwick Clinical Trials Research Unit: University of Warwick, Wolfson Centre for Age-Related Diseases: King’s College London | Leave a comment

Potential Association Between Tea Consumption and a Reduced Risk of Developing Dementia? (NHS Choices / Journal of Nutrition, Health and Aging)

Posted on April 23, 2017 by Dementia and Elderly Care News

Summary There is some evidence from Singapore that tea drinkers may be less likely to develop brain disorders such as dementia. Researchers discovered that Chinese elderly tea drinkers appeared to be less likely to develop dementia compared to non-drinkers. “The … Continue reading →

Posted in For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Nutrition, Quick Insights, Statistics, Universal Interest | Tagged Agency for Science Technology and Research, Alice Lim Memorial Fund, Alzheimer's Gene (APOE4 Gene), APOE e4 (Apolipoprotein E e4), Behind the Headlines, Biomedical Research Council, China, Chinese Elderly Tea Drinkers, Chinese Older Adults, Clinical Dementia Rating (CDR), Cognitive Benefits of Tea Drinking, Critical Appraisals, Department of Psychological Medicine: National University of Singapore, Epidemiology, Epidemiology and Statistics, Healthy Lifestyles, Journal of Nutrition Health and Aging, Lifestyle, Lifestyle Advice, Lifestyle Factors, Modified Mini-Mental State Examination (3-MS), National University Health System (Singapore), National University of Singapore, Neurocognitive Disorders, Neuroprotection Research, Neuroprotective Agents, Neuroprotective Lifestyles, Singapore, Singapore Longitudinal Ageing Studies (SLAS), Singapore Longitudinal Aging Study, Tea and Cognitive Health in Late Life, Tea Consumption, Tea Consumption and Dementia, Tea Drinking, Virtual Institute for the Study of Ageing, Yong Loo Lin School of Medicine: National University of Singapore | Leave a comment

Evidence Versus Mythology: Challenging Cherished Orthodoxies (British Journal of General Practice)

Posted on October 1, 2015 by Dementia and Elderly Care News

Summary A brief communication in the British Journal of General Practice points to recent evidence raising some interesting questions which many might prefer to duck. This “devil’s advocate”-style letter challenges readers to question some supposedly established axioms in modern dementia … Continue reading →

Posted in Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Quick Insights, UK, Universal Interest | Tagged ALSOVA 3-Year Follow-Up, Beck Depression Inventory (BDI), Brent Memory Service, British Journal of General Practice, Caregiver’s Level of Coping, Caregiver’s Mental Health, Caregivers' Health-Related Quality of Life (HRQoL) and Well-Being, Carers' Health-Related Quality of Life (HRQoL) and Well-Being, CDR Scale Sum of Boxes (CDR-sb), Clinical Dementia Rating (CDR), Consortium to Establish a Registry for Alzheimer's Disease Neuropsychological Battery (CERAD-NB), Dementia and Geriatric Cognitive Disorders Extra, Dementia Case Finding, Dementia Case Finding Scheme, Dementia Challenge, Dementia Crusade (sic), Dementia Diagnosis, Dementia Policy, Dementia Research Priorities, Dementia Screening Debate, Department of Primary Care and Population Health: University College London, Diagnosis and Referral, Drug Discovery Programmes, Early Diagnosis, Early Psychosocial Interventions for Dementia, Early Screening, Ethical Considerations, Ethical Issues of Dementia Care, Evidence Versus Mythology, Evidence-Based Medicine, Evidence-Based Policy, Evidence-Based Practice (EBP), General Health Questionnaire (GHQ), General Practice, Generalized Estimating Equations (GEEs), Gnosall Project, GPs, Incentive Payments, Incentives, International Journal of Geriatric Psychiatry, International Psychogeriatrics, Journal of Geriatric Psychiatry and Neurology, Kuopio ALSOVA Study, London, MCI: Mild Cognitive Impairment, Medical Ethics, Memory Clinics, Mild Cognitive Impairment (MCI), Misdiagnosis, Multiple Projectitis, Neuropsychiatric Symptoms of Alzheimer’s Disease, Over-Diagnosis, Overdiagnosis (Speculative Concept), Perverse Incentives, PLoS One, Post-Diagnosis Support, Post-Diagnostic Dementia Support, Potential Harms of Diagnosis, Prevalence of Dementia, Prevention Agenda, Prime Minister's Challenge on Dementia, Prime Minister’s Dementia Challenge, Primum Non Nocere, Quality of Life Research, Quality Premium Payments, Referral to Memory Clinics: Assessment, Risk of Overdiagnosis Associated With Screening, Screening, Screening for Dementia, Sense of Coherence (SOC), Short Version of the CERAD Neuropsychological Battery, Spousal Caregivers (SCs), Steve Iliffe: Professor of Primary Care for Older People; University College London, Target-Driven Behaviour, Target-Driven Priorities, Timely Diagnosis, University College London | Leave a comment

Tag Archives: Clinical Dementia Rating (CDR)

Potential Association Between Tea Consumption and a Reduced Risk of Developing Dementia? (NHS Choices / Journal of Nutrition, Health and Aging)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites